Bangor Savings Bank lifted its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 7.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 804 shares of the healthcare conglomerate’s stock after purchasing an additional 56 shares during the quarter. Bangor Savings Bank’s holdings in UnitedHealth Group were worth $407,000 at the end of the most recent quarter.
A number of other hedge funds also recently bought and sold shares of UNH. M&T Bank Corp boosted its stake in shares of UnitedHealth Group by 13.4% in the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after purchasing an additional 26,074 shares in the last quarter. Benjamin Edwards Inc. boosted its position in UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after buying an additional 41,308 shares during the period. Parsifal Capital Management LP purchased a new position in shares of UnitedHealth Group in the third quarter worth about $21,165,000. Discipline Wealth Solutions LLC purchased a new stake in UnitedHealth Group during the 3rd quarter valued at about $558,000. Finally, Franklin Resources Inc. lifted its position in UnitedHealth Group by 2.5% in the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock valued at $4,884,019,000 after purchasing an additional 193,800 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the stock. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Truist Financial cut their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday. TD Cowen lifted their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Barclays raised their target price on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 27th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Monday, December 9th. Three equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $627.58.
UnitedHealth Group Stock Performance
Shares of UNH opened at $513.84 on Wednesday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The business’s fifty day simple moving average is $557.79 and its two-hundred day simple moving average is $561.72. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $472.88 billion, a price-to-earnings ratio of 33.47, a P/E/G ratio of 1.53 and a beta of 0.62.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.56 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.63%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- What does consumer price index measure?
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- The Risks of Owning Bonds
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Stock Sentiment Analysis: How it Works
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.